Canadian Pharmacies Suggest Early Screening Reduces Risk of Colon Cancer in Men

A new research study has found men are more susceptible to colon cancer than women and therefore needed to undergo earlier screening. Colorectal cancer does not indicate many early symptoms. Chances of developing polyps or adenomas in the colon increase after the age of 50 years. Canadian pharmacies therefore suggest early screening, especially in men, as research findings indicate age does play an important role in developing potentially precancerous lesions.

Around 44,350 Austrians volunteered for a national colonoscopy screening program. Men with an average age of 60.7 years and women averaging 60.6 years were selected. People below the age of 50 years were just 1,600 in number. Studies conducted earlier indicated men were at greater risk of developing advanced colorectal cancer in comparison to women, which triggered the current study by researchers from the Austrian Medical University of Vienna.

Colorectal cancer usually originates at the end of colon or large intestine. The American Cancer Society has indicated it is one of the major reasons for death due to cancer in the United States. The good news is early diagnosis invariably results in complete cure. Results of the current study therefore has great importance, as men found positive for adenomas during early screening of colorectal cancer may have greater chance of finding a permanent cure, if they go in for early screening tests. Canadian pharmacies suggest men over 40 years old must go in for colorectal cancer screening.

Published in the Journal of the American Medical Association on Sept. 28, the present study findings recorded a 24.9% chance of having adenomas in the colon as compared to 14.8% in women. Moreover, results clearly indicated men had a higher risk of getting them a few years earlier. An analysis of sex-specific and age-related prevalence of polyps, advanced adenomas, and resultant colorectal cancer was made. Males were connected to an independent risk factor which suggested earlier screening may be beneficial in detecting potentially precancerous lesions.

However, some experts believe the study did not consider a sizeable number of volunteers under the age of 50 years to require drastic changes in screening guidelines. It was pointed out volunteers already with a high risk of colon cancer constituted a majority of under-45 candidates participating in the study. Indications did suggest further research is warranted, but gender-based screening variations could not be implemented in a structured manner until further clinical research supported the move.

A direct connection was made between age and risk of colon cancer. Around 19% of male volunteers between 50 and 54 years of age develop polyps, while just 11% women in the same age group indicated similar symptoms. However, after the age of 65 years, the difference reduced and both men and women had equal risk.

Summary of the findings led researchers to believe 34% polyps, 0.4% colon cancer, and 0.2% rectal cancer among volunteers, both male and female, suggest early screening may offer better chance to stop polyps from turning into precancerous adenomas resulting in colon cancer. According to Online Canadian pharmacies, regular checkups after the age of 45 years were required, especially in those experiencing tenderness and lower abdominal pain or passing blood in the stool.